Email : connect@novatrendsmarketintelligence.com
logo
☰

Healthcare & Pharmaceutical

Region

Research Reports in Healthcare & Pharmaceutical

Clinical Trials Market Size, Share & Forecast, By Phase (Phase I, II, III, IV), By Study Design (Interventional, Observational, Expanded Access), By Therapeutic Area (Oncology, Cardiovascular, Infectious Diseases), By Service Provider (CROs, In-House), By Region, 2025–2032

Decentralized trials, real-world evidence, and adaptive study designs are reshaping the clinical trial landscape. Pharma and biotech companies are increasingly outsourcing to CROs for speed, compliance, and access to diverse patient pools.

Read More »

June 2025

Neurodegenerative Disease Therapeutics Market Size, By Indication (Alzheimer’s, Parkinson’s, ALS, Huntington’s), By Drug Class (Cholinesterase Inhibitors, Dopamine Agonists, Antidepressants, NMDA Antagonists), By Route of Administration, By Distribution Channel, By Region, 2025–2032

With aging populations and rising prevalence of Alzheimer’s and Parkinson’s, demand for effective therapeutics is rising. Investments in disease-modifying treatments, early diagnosis tools, and biotech-led innovation are transforming care models.

Read More »

June 2025

Biopharmaceutical Contract Manufacturing Market Size, Share & Trends, By Service Type (Mammalian, Microbial, Fill-Finish, Cell Banking), By Molecule (Monoclonal Antibodies, Vaccines, Recombinant Proteins), By Client Type (Big Pharma, Biotech Startups), By Region, 2025–2032

Biologics outsourcing is booming due to the surge in mAb, vaccine, and gene therapy production. Pharma companies are leveraging CDMOs to scale pipelines quickly, reduce CAPEX, and accelerate market entry with regulatory-compliant infrastructure.

Read More »

June 2025

Digital Health Market Size, Trends & Forecast, By Technology (Telehealth, mHealth, AI in Healthcare, Digital Therapeutics, RPM), By Component (Software, Services, Hardware), By End Use (Hospitals, Homecare, Payers), By Region, 2025–2032

Rising chronic diseases, aging populations, and post-pandemic digital transformation have driven adoption of telemedicine, remote patient monitoring, and AI-based diagnostics.

Read More »

June 2025

mRNA Therapeutics Market Size, Share & Forecast, By Type (Prophylactic Vaccines, Therapeutic Vaccines, mRNA Cancer Immunotherapies), By Application (Infectious Diseases, Oncology, Genetic Disorders), By Delivery Method (Lipid Nanoparticles, Electroporation), By Region, 2025–2032

The success of mRNA COVID-19 vaccines has validated the platform’s scalability and adaptability. Investments in oncology, personalized vaccines, and rare genetic disorders are accelerating R&D and market growth for mRNA-based therapeutics.

Read More »

June 2025

Cell & Gene Therapy Market Size, Share & Trends, By Therapy Type (CAR-T, CRISPR, Gene Silencing, Stem Cell), By Indication (Cancer, Rare Diseases, Genetic Disorders, Neurology), By Delivery Mode (In Vivo, Ex Vivo), By Region, 2025–2032

Breakthroughs in CRISPR, CAR-T, and stem cell platforms are revolutionizing treatments for rare and genetic diseases. Regulatory fast-tracks and strong biotech funding are accelerating clinical pipelines and commercial success of curative

Read More »

June 2025

logo

Navigating Tomorrow's Insights Today

connect@novatrendsmarketintelligence.com

Copyright © 2025 Novatrends Market Intelligence. All Rights Reserved Developed by Nivtech

we use cookie for improve your experience

We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy . By continuing to use this site, or closing this box, you consent to our use of cookies. More info .